Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport New Facility Efficacy in Cervical Dystonia
NCT00257660Phase 3Completed
- Sponsor
- Ipsen
- Start
- Oct 2005
- Primary completion
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of abobotulinumtoxinA in cervical dystonia (CD), sponsored by Ipsen. Started Oct 2005; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00257660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257660.